Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,689 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.
Kanda M, Shimizu D, Tanaka H, Shibata M, Iwata N, Hayashi M, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Kanda M, et al. Among authors: shibata m. Oncotarget. 2016 Mar 22;7(12):13667-79. doi: 10.18632/oncotarget.7269. Oncotarget. 2016. PMID: 26872374 Free PMC article.
Neurotrophin Receptor-Interacting Melanoma Antigen-Encoding Gene Homolog is Associated with Malignant Phenotype of Gastric Cancer.
Kanda M, Shimizu D, Fujii T, Tanaka H, Tanaka Y, Ezaka K, Shibata M, Takami H, Hashimoto R, Sueoka S, Iwata N, Kobayashi D, Tanaka C, Yamada S, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Kanda M, et al. Among authors: shibata m. Ann Surg Oncol. 2016 Aug;23(Suppl 4):532-539. doi: 10.1245/s10434-016-5375-0. Epub 2016 Jun 30. Ann Surg Oncol. 2016. PMID: 27364510
The protein arginine methyltransferase 5 promotes malignant phenotype of hepatocellular carcinoma cells and is associated with adverse patient outcomes after curative hepatectomy.
Shimizu D, Kanda M, Sugimoto H, Shibata M, Tanaka H, Takami H, Iwata N, Hayashi M, Tanaka C, Kobayashi D, Yamada S, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. Shimizu D, et al. Among authors: shibata m. Int J Oncol. 2017 Feb;50(2):381-386. doi: 10.3892/ijo.2017.3833. Epub 2017 Jan 2. Int J Oncol. 2017. PMID: 28101581 Free PMC article.
Expression of regulatory factor X1 can predict the prognosis of breast cancer.
Shibata M, Kanda M, Shimizu D, Tanaka H, Umeda S, Hayashi M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Kodera Y, Kikumori T. Shibata M, et al. Oncol Lett. 2017 Jun;13(6):4334-4340. doi: 10.3892/ol.2017.6005. Epub 2017 Apr 7. Oncol Lett. 2017. PMID: 28599435 Free PMC article.
Feasibility of dose-dense epirubicin and cyclophosphamide with subcutaneous pegfilgrastim 3.6 mg support: a single-center prospective study in Japan.
Morita S, Kikumori T, Tsunoda N, Inaishi T, Adachi Y, Ota A, Shibata M, Matsuoka A, Nakanishi K, Takeuchi D, Mizutani T, Shimokata T, Hayashi H, Maeda O, Ando Y. Morita S, et al. Among authors: shibata m. Int J Clin Oncol. 2018 Feb;23(1):195-200. doi: 10.1007/s10147-017-1177-z. Epub 2017 Aug 8. Int J Clin Oncol. 2018. PMID: 28791509 Clinical Trial.
2,689 results